|
1.
|
Katz PM, Leung AM, Braverman LE, Pearce EN, Tomlinson G, He X, Vertes J, Okun N, Walfish PG, Feig DS. Iodine nutrition during pregnancy in toronto, Canada. Endocr Pract. 2013 Mar-Apr; 19(2):206-11.
|
|
|
|
|
2.
|
Leung AM, He X, Pearce EN, Braverman LE. Perchlorate Concentrations in Boston's Charles River After the July 4th Fireworks Spectacular. Thyroid. 2013 Mar; 23(3):378-9.
|
|
|
|
|
3.
|
Braverman LE, Magner JA. Introduction To The Recombinant Human TSH (rhTSH) Symposium Articles. Endocr Pract. 2013 Jan 1; 19(1):137-8.
|
|
|
|
|
4.
|
Steenkamp DW, Junqueira A, Braverman LE. Unusual problems in the management of hyperthyroid graves' disease. Endocr Pract. 2013 Jan 1; 19(1):162-5.
|
|
|
|
|
5.
|
Leung AM, Pearce EN, Braverman LE. Sufficient iodine intake during pregnancy: just do it. Thyroid. 2013 Jan; 23(1):7-8.
|
|
|
|
|
6.
|
Leung AM, Braverman LE, Pearce EN. History of u.s. Iodine fortification and supplementation. Nutrients. 2012; 4(11):1740-6.
|
|
|
|
|
7.
|
Leung AM, Braverman LE, He X, Heeren T, Pearce EN. Breastmilk iodine concentrations following acute dietary iodine intake. Thyroid. 2012 Nov; 22(11):1176-80.
|
|
|
|
|
8.
|
Braverman LE. Editorial. Curr Opin Endocrinol Diabetes Obes. 2012 Oct; 19(5):381.
|
|
|
|
|
9.
|
Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012 Oct; 19(5):414-9.
|
|
|
|
|
10.
|
Connelly KJ, Boston BA, Pearce EN, Sesser D, Snyder D, Braverman LE, Pino S, Lafranchi SH. Congenital hypothyroidism caused by excess prenatal maternal iodine ingestion. J Pediatr. 2012 Oct; 161(4):760-2.
|
|
|
|
|
11.
|
Leung AM, Braverman LE, He X, Schuller KE, Roussilhes A, Jahreis KA, Pearce EN. Environmental perchlorate and thiocyanate exposures and infant serum thyroid function. Thyroid. 2012 Sep; 22(9):938-43.
|
|
|
|
|
12.
|
Pearce EN, Alexiou M, Koukkou E, Braverman LE, He X, Ilias I, Alevizaki M, Markou KB. Perchlorate and Thiocyanate Exposure and Thyroid Function in First Trimester Pregnant Women from Greece. Clin Endocrinol (Oxf). 2012 Apr 9.
|
|
|
|
|
13.
|
Belfort MB, Pearce EN, Braverman LE, He X, Brown RS. Low iodine content in the diets of hospitalized preterm infants. J Clin Endocrinol Metab. 2012 Apr; 97(4):E632-6.
|
|
|
|
|
14.
|
Braverman LE. Editor's 5-Year Report. Endocr Pract. 2012 Jan 1; 18(1):7.
|
|
|
|
|
15.
|
Leung AM, Pearce EN, Braverman LE. Iodine nutrition in pregnancy and lactation. Endocrinol Metab Clin North Am. 2011 Dec; 40(4):765-77.
|
|
|
|
|
16.
|
Pramyothin P, Leung AM, Pearce EN, Malabanan AO, Braverman LE. Clinical problem-solving. A hidden solution. N Engl J Med. 2011 Dec 1; 365(22):2123-7.
|
|
|
|
|
17.
|
Rhee SS, Braverman LE, Pino S, He X, Pearce EN. High iodine content of korean seaweed soup: a health risk for lactating women and their infants? Thyroid. 2011 Aug; 21(8):927-8.
|
|
|
|
|
18.
|
Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid Testing during Pregnancy at an Academic Boston Area Medical Center. J Clin Endocrinol Metab. 2011 Sep; 96(9):E1452-6.
|
|
|
|
|
19.
|
Leung AM, Lamar A, He X, Braverman LE, Pearce EN. Iodine status and thyroid function of Boston-area vegetarians and vegans. J Clin Endocrinol Metab. 2011 Aug; 96(8):E1303-7.
|
|
|
|
|
20.
|
Pearce EN, Spencer CA, Mestman JH, Lee RH, Bergoglio LM, Mereshian P, He X, Leung AM, Braverman LE. Effect of environmental perchlorate on thyroid function in pregnant women from córdoba, Argentina, and los angeles, california. Endocr Pract. 2011 May-Jun; 17(3):412-7.
|
|
|
|
|
21.
|
Graf H, Fast S, Pacini F, Pinchera A, Leung A, Vaisman M, Reiners C, Wemeau JL, Huysmans D, Harper W, Driedger A, de Souza HN, Castagna MG, Antonangeli L, Braverman L, Corbo R, Düren C, Proust-Lemoine E, Edelbroek MA, Marriott C, Rachinsky I, Grupe P, Watt T, Magner J, Hegedus L. Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study. J Clin Endocrinol Metab. 2011 May; 96(5):1368-76.
|
|
|
|
|
22.
|
Lee SY, Leung AM, He X, Braverman LE, Pearce EN. Iodine Content in Fast Foods: Comparison Between two Fast-Food Chains in the United States. Endocr Pract. 2010 Nov-Dec; 16(6):1071-2.
|
|
|
|
|
23.
|
Pearce EN, Lazarus JH, Smyth PP, He X, Dall'amico D, Parkes AB, Burns R, Smith DF, Maina A, Bestwick JP, Jooman M, Leung AM, Braverman LE. Perchlorate and thiocyanate exposure and thyroid function in first-trimester pregnant women. J Clin Endocrinol Metab. 2010 Jul; 95(7):3207-15.
|
|
|
|
|
24.
|
Leung AM, Pearce EN, Braverman LE. Perchlorate, iodine and the thyroid. Best Pract Res Clin Endocrinol Metab. 2010 Feb; 24(1):133-41.
|
|
|
|
|
25.
|
Pearce EN, Braverman LE. Environmental pollutants and the thyroid. Best Pract Res Clin Endocrinol Metab. 2009 Dec; 23(6):801-13.
|
|
|
|
|
26.
|
Pearce EN, Lazarus JH, Smyth PP, He X, Smith DF, Pino S, Braverman LE. Urine test strips as a source of iodine contamination. Thyroid. 2009 Aug; 19(8):919.
|
|
|
|
|
27.
|
Kim YH, Pham TD, Zheng W, Hong S, Baylis C, Pech V, Beierwaltes WH, Farley DB, Braverman LE, Verlander JW, Wall SM. Role of pendrin in iodide balance: going with the flow. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1069-79.
|
|
|
|
|
28.
|
Braverman L. The relationship between the pharmaceutical industry and the medical profession--have we lost our way? Endocr Pract. 2009 May-Jun; 15(4):290.
|
|
|
|
|
29.
|
Tenpenny KE, Trent CJ, Sutherland PA, Van Middlesworth L, Williams-Cleaves B, Braverman LE. Evidence of endemic goiter and iodine deficiency in a mountainous area of Haiti. Endocr Pract. 2009 May-Jun; 15(4):298-301.
|
|
|
|
|
30.
|
Leung AM, Pearce EN, Braverman LE. Iodine content of prenatal multivitamins in the United States. N Engl J Med. 2009 Feb 26; 360(9):939-40.
|
|
|
|
|
31.
|
Arum SM, He X, Braverman LE. Excess iodine from an unexpected source. N Engl J Med. 2009 Jan 22; 360(4):424-6.
|
|
|
|
|
32.
|
Teas J, Baldeón ME, Chiriboga DE, Davis JR, Sarriés AJ, Braverman LE. Could dietary seaweed reverse the metabolic syndrome? Asia Pac J Clin Nutr. 2009; 18(2):145-54.
|
|
|
|
|
33.
|
Joffe HV, Emerson CH, Braverman LE. Dr. Robert David ("Bob") Utiger, 1931-2008. Thyroid. 2009 Jan; 19(1):81-2.
|
|
|
|
|
34.
|
Braverman LE. Environmental perchlorate: perhaps much ado about nothing. Endocr Pract. 2009 Jan-Feb; 15(1):50-2.
|
|
|
|
|
35.
|
Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE, Goodwin TM. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009 Mar; 200(3):260.e1-6.
|
|
|
|
|
36.
|
Oken E, Braverman LE, Platek D, Mitchell ML, Lee SL, Pearce EN. Neonatal thyroxine, maternal thyroid function, and child cognition. J Clin Endocrinol Metab. 2009 Feb; 94(2):497-503.
|
|
|
|
|
37.
|
Benvenga S, Ordookhani A, Pearce EN, Tonacchera M, Azizi F, Braverman LE. Detection of circulating autoantibodies against thyroid hormones in an infant with permanent congenital hypothyroidism and her twin with transient congenital hypothyroidism: possible contribution of thyroid hormone autoantibodies to neonatal and infant hypothyroidism. J Pediatr Endocrinol Metab. 2008 Oct; 21(10):1011-20.
|
|
|
|
|
38.
|
Braverman L, Kloos RT, Law B, Kipnes M, Dionne M, Magner J. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters. Endocr Pract. 2008 Oct; 14(7):832-9.
|
|
|
|
|
39.
|
Roti E, degli Uberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008 Dec; 159(6):659-73.
|
|
|
|
|
40.
|
Leung AM, Pearce EN, Hamilton T, He X, Pino S, Merewood A, Braverman LE. Colostrum iodine and perchlorate concentrations in Boston-area women: a cross-sectional study. Clin Endocrinol (Oxf). 2009 Feb; 70(2):326-30.
|
|
|
|
|
41.
|
Ananthakrishnan S, Braverman LE, Levin RM, Magnani B, Pearce EN. The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption. Thyroid. 2008 May; 18(5):493-8.
|
|
|
|
|
42.
|
Sanyal P, Bing-You RG, Braverman LE. Use of methotrexate to treat isolated Graves ophthalmopathy developing years after thyroidectomy and iodine 131 treatment of papillary thyroid cancer. Endocr Pract. 2008 May-Jun; 14(4):422-5.
|
|
|
|
|
43.
|
Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf). 2008 Nov; 69(5):812-8.
|
|
|
|
|
44.
|
Rossi R, Roti E, Trasforini G, Pansini G, Cavazzini L, Zatelli MC, Pearce EN, Braverman LE, Uberti EC. Differentiated thyroid cancers 11-20 mm in diameter have clinical and histopathologic characteristics suggesting higher aggressiveness than those < or =10 mm. Thyroid. 2008 Mar; 18(3):309-15.
|
|
|
|
|
45.
|
Flanagan JN, Pineda P, Knapp PE, De Las Morenas A, Lee SL, Braverman LE. Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction. Endocr Pract. 2008 Mar; 14(2):168-74.
|
|
|
|
|
46.
|
Ceresini G, Milli B, Morganti S, Maggio M, Bacchi-Modena A, Sgarabotto MP, Chirico C, Di Donato P, Campanati P, Valcavi R, Ceda GP, Braverman LE, Valenti G. Effect of estrogen therapy for 1 year on thyroid volume and thyroid nodules in postmenopausal women. Menopause. 2008 Mar-Apr; 15(2):326-31.
|
|
|
|
|
47.
|
Rayburn WF, Robinson A, Braverman LE, He XM, Pino S, Gargas ML, Kinzell JH. Iodide concentrations in matched maternal serum, cord serum, and amniotic fluid from preterm and term human pregnancies. Reprod Toxicol. 2008 Jan; 25(1):129-32.
|
|
|
|
|
48.
|
Pearce EN, Oken E, Gillman MW, Lee SL, Magnani B, Platek D, Braverman LE. Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use. Endocr Pract. 2008 Jan-Feb; 14(1):33-9.
|
|
|
|
|
49.
|
Ordookhani A, Pearce EN, Mirmiran P, Azizi F, Braverman LE. Transient congenital hypothyroidism in an iodine-replete area is not related to parental consanguinity, mode of delivery, goitrogens, iodine exposure, or thyrotropin receptor autoantibodies. J Endocrinol Invest. 2008 Jan; 31(1):29-34.
|
|
|
|
|
50.
|
Pearce EN, Wilson PW, Yang Q, Vasan RS, Braverman LE. Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab. 2008 Mar; 93(3):888-94.
|
|
|
|
|
51.
|
Ordookhani A, Pearce EN, Mirmiran P, Azizi F, Braverman LE. The effect of type of delivery and povidone-iodine application at delivery on cord dried-blood-specimen thyrotropin level and the rate of hyperthyrotropinemia in mature and normal-birth-weight neonates residing in an iodine-replete area: report of Tehran Province, 1998-2005. Thyroid. 2007 Nov; 17(11):1097-102.
|
|
|
|
|
52.
|
Brent GA, Braverman LE, Zoeller RT. Thyroid health and the environment. Thyroid. 2007 Sep; 17(9):807-9.
|
|
|
|
|
53.
|
Braverman LE. Clinical studies of exposure to perchlorate in the United States. Thyroid. 2007 Sep; 17(9):819-22.
|
|
|
|
|
54.
|
Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab. 2007 Nov; 92(11):4236-40.
|
|
|
|
|
55.
|
Leung AM, Braverman LE, Pearce EN. A dietary iodine questionnaire: correlation with urinary iodine and food diaries. Thyroid. 2007 Aug; 17(8):755-62.
|
|
|
|
|
56.
|
Rago T, Di Coscio G, Ugolini C, Scutari M, Basolo F, Latrofa F, Romani R, Berti P, Grasso L, Braverman LE, Pinchera A, Vitti P. Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol (Oxf). 2007 Sep; 67(3):363-9.
|
|
|
|
|
57.
|
Papi G, Uberti ED, Betterle C, Carani C, Pearce EN, Braverman LE, Roti E. Subclinical hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2007 Jun; 14(3):197-208.
|
|
|
|
|
58.
|
Ordookhani A, Pearce EN, Hedayati M, Mirmiran P, Salimi S, Azizi F, Braverman LE. Assessment of thyroid function and urinary and breast milk iodine concentrations in healthy newborns and their mothers in Tehran. Clin Endocrinol (Oxf). 2007 Aug; 67(2):175-9.
|
|
|
|
|
59.
|
McLanahan ED, Campbell JL, Ferguson DC, Harmon B, Hedge JM, Crofton KM, Mattie DR, Braverman L, Keys DA, Mumtaz M, Fisher JW. Low-dose effects of ammonium perchlorate on the hypothalamic-pituitary-thyroid axis of adult male rats pretreated with PCB126. Toxicol Sci. 2007 Jun; 97(2):308-17.
|
|
|
|
|
60.
|
Teas J, Braverman LE, Kurzer MS, Pino S, Hurley TG, Hebert JR. Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J Med Food. 2007 Mar; 10(1):90-100.
|
|
|
|
|
61.
|
Malasanos T, Chaudhari M, Selman-Almonte A, Pino S, Previti M, Braverman L, Rosenbloom A. Iodine deficiency, iodine content of salt and knowledge of iodine supplementation in the Dominican Republic. J Trop Pediatr. 2007 Jun; 53(3):214-6.
|
|
|
|
|
62.
|
Pearce EN, Leung AM, Blount BC, Bazrafshan HR, He X, Pino S, Valentin-Blasini L, Braverman LE. Breast milk iodine and perchlorate concentrations in lactating Boston-area women. J Clin Endocrinol Metab. 2007 May; 92(5):1673-7.
|
|
|
|
|
63.
|
Pearce EN, Braverman LE. Is amiodarone-induced thyrotoxicosis associated with increased mortality? Nat Clin Pract Endocrinol Metab. 2006 Dec; 2(12):668-9.
|
|
|
|
|
64.
|
Iodine supplementation for pregnancy and lactation-United States and Canada: recommendations of the American Thyroid Association. Thyroid. 2006 Oct; 16(10):949-51.
|
|
|
|
|
65.
|
Ness-Abramof R, Nabriski DA, Braverman LE, Shilo L, Weiss E, Reshef T, Shapiro MS, Shenkman L. Prevalence and evaluation of B12 deficiency in patients with autoimmune thyroid disease. Am J Med Sci. 2006 Sep; 332(3):119-22.
|
|
|
|
|
66.
|
Liu Z, Braverman LE, Malabanan A. Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocr Pract. 2006 Jul-Aug; 12(4):427-31.
|
|
|
|
|
67.
|
McDonnell ME, Braverman LE. Drug-related hepatotoxicity. N Engl J Med. 2006 May 18; 354(20):2191-3; author reply 2191-3.
|
|
|
|
|
68.
|
Braverman LE, Pearce EN, He X, Pino S, Seeley M, Beck B, Magnani B, Blount BC, Firek A. Effects of six months of daily low-dose perchlorate exposure on thyroid function in healthy volunteers. J Clin Endocrinol Metab. 2006 Jul; 91(7):2721-4.
|
|
|
|
|
69.
|
Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Nersita R, Iorio S, Amato G, Braverman LE, Roti E. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid. 2006 Mar; 16(3):295-302.
|
|
|
|
|
70.
|
Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab. 2006 Jun; 91(6):2171-8.
|
|
|
|
|
71.
|
Ruberg FL, McDonnell ME, Trabb J, Shemin RJ, Hoyt RF, Braverman LE, Balady GJ. An intracardiac accessory thyroid gland. Am J Cardiol. 2006 Mar 15; 97(6):926-8.
|
|
|
|
|
72.
|
Schroeder PR, Haugen BR, Pacini F, Reiners C, Schlumberger M, Sherman SI, Cooper DS, Schuff KG, Braverman LE, Skarulis MC, Davies TF, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Weintraub BD, Ridgway EC, Ladenson PW. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab. 2006 Mar; 91(3):878-84.
|
|
|
|
|
73.
|
Pena S, Arum S, Cross M, Magnani B, Pearce EN, Oates ME, Braverman LE. 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers. J Clin Endocrinol Metab. 2006 Feb; 91(2):506-10.
|
|
|
|
|
74.
|
Arum SM, Dahia PL, Schneider K, Braverman LE. A RET mutation with decreased penetrance in the family of a patient with a "sporadic" pheochromocytoma. Endocrine. 2005 Nov; 28(2):193-8.
|
|
|
|
|
75.
|
Bazrafshan HR, Mohammadian S, Ordookhani A, Abedini A, Davoudy R, Pearce EN, Hedayati M, Azizi F, Braverman LE. An assessment of urinary and breast milk iodine concentrations in lactating mothers from Gorgan, Iran, 2003. Thyroid. 2005 Oct; 15(10):1165-8.
|
|
|
|
|
76.
|
Bazrafshan HR, Mohammadian S, Ordookhani A, Farhidmehr F, Hedayati M, Abdolahi N, Azizi F, Braverman LE, Pearce EN. Prevalence of goiter among schoolchildren from Gorgan, Iran, a decade after national iodine supplementation: association with age, gender, and thyroperoxidase antibodies. J Endocrinol Invest. 2005 Sep; 28(8):727-33.
|
|
|
|
|
77.
|
Braverman LE, Pearce EN. Comment on "Perchlorate and iodide in dairy and breast milk". Environ Sci Technol. 2005 Jul 15; 39(14):5498; author reply 5499-500.
|
|
|
|
|
78.
|
McDonnell ME, Braverman LE, Bernardo J. Hypothyroidism due to ethionamide. N Engl J Med. 2005 Jun 30; 352(26):2757-9.
|
|
|
|
|
79.
|
Papi G, Papi G, Pearce EN, Braverman LE, Betterle C, Roti E. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only. Am J Med. 2005 Apr; 118(4):349-61.
|
|
|
|
|
80.
|
Braverman LE. An interview with Lewis E. Braverman M.D. Thyroid. 2005 Mar; 15(3):188-96.
|
|
|
|
|
81.
|
David A, Blotta A, Rossi R, Zatelli MC, Bondanelli M, Roti E, Braverman LE, Busutti L, degli Uberti EC. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. Thyroid. 2005 Mar; 15(3):267-73.
|
|
|
|
|
82.
|
David A, Blotta A, Rossi R, Zatelli MC, Bondanelli M, Roti E, Braverman LE, Busutti L, degli Uberti EC. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma. Thyroid. 2005 Feb; 15(2):158-64.
|
|
|
|
|
83.
|
Braverman LE, He X, Pino S, Cross M, Magnani B, Lamm SH, Kruse MB, Engel A, Crump KS, Gibbs JP. The effect of perchlorate, thiocyanate, and nitrate on thyroid function in workers exposed to perchlorate long-term. J Clin Endocrinol Metab. 2005 Feb; 90(2):700-6.
|
|
|
|
|
84.
|
Teas J, Pino S, Critchley A, Braverman LE. Variability of iodine content in common commercially available edible seaweeds. Thyroid. 2004 Oct; 14(10):836-41.
|
|
|
|
|
85.
|
Carella C, Mazziotti G, Amato G, Braverman LE, Roti E. Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metab. 2004 Aug; 89(8):3656-61.
|
|
|
|
|
86.
|
Pearce EN, Braverman LE. Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab. 2004 Aug; 89(8):3710-2.
|
|
|
|
|
87.
|
Pearce EN, Braverman LE. Pemberton's sign. N Engl J Med. 2004 Jul 8; 351(2):196; author reply 196.
|
|
|
|
|
88.
|
Pearce EN, Pino S, He X, Bazrafshan HR, Lee SL, Braverman LE. Sources of dietary iodine: bread, cows' milk, and infant formula in the Boston area. J Clin Endocrinol Metab. 2004 Jul; 89(7):3421-4.
|
|
|
|
|
89.
|
Pearce EN, Braverman LE. Hyperthyroidism: advantages and disadvantages of medical therapy. Surg Clin North Am. 2004 Jun; 84(3):833-47.
|
|
|
|
|
90.
|
Panzer C, Beazley R, Braverman L. Rapid preoperative preparation for severe hyperthyroid Graves' disease. J Clin Endocrinol Metab. 2004 May; 89(5):2142-4.
|
|
|
|
|
91.
|
Pearce EN, Bazrafshan HR, He X, Pino S, Braverman LE. Dietary iodine in pregnant women from the Boston, Massachusetts area. Thyroid. 2004 Apr; 14(4):327-8.
|
|
|
|
|
92.
|
Blakesley V, Awni W, Locke C, Ludden T, Granneman GR, Braverman LE. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid. 2004 Mar; 14(3):191-200.
|
|
|
|
|
93.
|
Ceresini G, Morganti S, Rebecchi I, Bertone L, Ceda GP, Bacchi-Modena A, Sgarabotto M, Baldini M, Ablondi F, Valenti G, Braverman LE. A one-year follow-up on the effects of raloxifene on thyroid function in postmenopausal women. Menopause. 2004 Mar-Apr; 11(2):176-9.
|
|
|
|
|
94.
|
Ryan LE, Braverman LE, Cooper DS, Ladenson PW, Kloos RT. Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? Thyroid. 2004 Feb; 14(2):149-53.
|
|
|
|
|
95.
|
Zimmermann MB, Hess SY, Molinari L, De Benoist B, Delange F, Braverman LE, Fujieda K, Ito Y, Jooste PL, Moosa K, Pearce EN, Pretell EA, Shishiba Y. New reference values for thyroid volume by ultrasound in iodine-sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report. Am J Clin Nutr. 2004 Feb; 79(2):231-7.
|
|
|
|
|
96.
|
Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med. 2003 Sep 2; 139(5 Pt 1):346-51.
|
|
|
|
|
97.
|
Pearce EN, Bogazzi F, Martino E, Brogioni S, Pardini E, Pellegrini G, Parkes AB, Lazarus JH, Pinchera A, Braverman LE. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid. 2003 Jul; 13(7):643-8.
|
|
|
|
|
98.
|
Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini-Lombardi F, Ceccarelli C, Pinchera A, Bartalena L, Braverman LE. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest. 2003 Jul; 26(7):635-40.
|
|
|
|
|
99.
|
Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003 Jun 26; 348(26):2646-55.
|
|
|
|
|
100.
|
Caldwell KL, Maxwell CB, Makhmudov A, Pino S, Braverman LE, Jones RL, Hollowell JG. Use of inductively coupled plasma mass spectrometry to measure urinary iodine in NHANES 2000: comparison with previous method. Clin Chem. 2003 Jun; 49(6 Pt 1):1019-21.
|
|
|
|
|
101.
|
Santini F, Vitti P, Chiovato L, Ceccarini G, Macchia M, Montanelli L, Gatti G, Rosellini V, Mammoli C, Martino E, Chopra IJ, Safer JD, Braverman LE, Pinchera A. Role for inner ring deiodination preventing transcutaneous passage of thyroxine. J Clin Endocrinol Metab. 2003 Jun; 88(6):2825-30.
|
|
|
|
|
102.
|
Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell'Unto E, Grasso L, Aghini-Lombardi F, Rossi G, Pinchera A, Braverman LE, Martino E. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. J Clin Endocrinol Metab. 2003 May; 88(5):1999-2002.
|
|
|
|
|
103.
|
Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003 Apr; 88(4):1433-41.
|
|
|
|
|
104.
|
Pearce EN, Gerber AR, Gootnick DB, Khan LK, Li R, Pino S, Braverman LE. Effects of chronic iodine excess in a cohort of long-term American workers in West Africa. J Clin Endocrinol Metab. 2002 Dec; 87(12):5499-502.
|
|
|
|
|
105.
|
Bogazzi F, Miccoli P, Berti P, Cosci C, Brogioni S, Aghini-Lombardi F, Materazzi G, Bartalena L, Pinchera A, Braverman LE, Martino E. Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery. 2002 Dec; 132(6):1114-7; discussion 1118.
|
|
|
|
|
106.
|
Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, Braverman LE. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002 Jul; 87(7):3221-6.
|
|
|
|
|
107.
|
Lee TI, Yang HJ, Lin SY, Lee MT, Lin HD, Braverman LE, Tang KT. The accuracy of fine-needle aspiration biopsy and frozen section in patients with thyroid cancer. Thyroid. 2002 Jul; 12(7):619-26.
|
|
|
|
|
108.
|
Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb; 87(2):489-99.
|
|
|
|
|
109.
|
Bogazzi F, Aghini-Lombardi F, Cosci C, Lupi I, Santini F, Tanda ML, Miccoli P, Basolo F, Pinchera A, Bartalena L, Braverman LE, Martino E. Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. J Endocrinol Invest. 2002 Feb; 25(2):176-80.
|
|
|
|
|
110.
|
David A, Blotta A, Bondanelli M, Rossi R, Roti E, Braverman LE, Busutti L, degli Uberti EC. Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone. J Nucl Med. 2001 Oct; 42(10):1470-5.
|
|
|
|
|
111.
|
Soldin OP, Braverman LE, Lamm SH. Perchlorate clinical pharmacology and human health: a review. Ther Drug Monit. 2001 Aug; 23(4):316-31.
|
|
|
|
|
112.
|
Braverman LE. The physiology and pathophysiology of iodine and the thyroid. Thyroid. 2001 May; 11(5):405.
|
|
|
|
|
113.
|
Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E. The various effects of amiodarone on thyroid function. Thyroid. 2001 May; 11(5):511-9.
|
|
|
|
|
114.
|
Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001 Apr; 22(2):240-54.
|
|
|
|
|
115.
|
Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab. 2001 Apr; 86(4):1660-4.
|
|
|
|
|
116.
|
Lawrence J, Lamm S, Braverman LE. Low dose perchlorate (3 mg daily) and thyroid function. Thyroid. 2001 Mar; 11(3):295.
|
|
|
|
|
117.
|
Eng PH, Cardona GR, Previti MC, Chin WW, Braverman LE. Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol. 2001 Feb; 144(2):139-44.
|
|
|
|
|
118.
|
Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest. 2001 Feb; 24(2):116-30.
|
|
|
|
|
119.
|
Lawrence JE, Emerson CH, Sullaway SL, Braverman LE. The effect of recombinant human tsh on the thyroid (123)i uptake in iodide treated normal subjects. J Clin Endocrinol Metab. 2001 Jan; 86(1):437-40.
|
|
|
|
|
120.
|
McMonigal KA, Braverman LE, Dunn JT, Stanbury JB, Wear ML, Hamm PB, Sauer RL, Billica RD, Pool SL. Thyroid function changes related to use of iodinated water in the U.S. Space Program. Aviat Space Environ Med. 2000 Nov; 71(11):1120-5.
|
|
|
|
|
121.
|
Marqusee E, Braverman LE, Lawrence JE, Carroll JS, Seely EW. The effect of droloxifene and estrogen on thyroid function in postmenopausal women. J Clin Endocrinol Metab. 2000 Nov; 85(11):4407-10.
|
|
|
|
|
122.
|
Marinò M, Barbesino G, Pinchera A, Manetti L, Ricciardi R, Rossi B, Muratorio A, Braverman LE, Mariotti S, Chiovato L. Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis. Thyroid. 2000 Sep; 10(9):799-802.
|
|
|
|
|
123.
|
Lawrence JE, Lamm SH, Pino S, Richman K, Braverman LE. The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid. 2000 Aug; 10(8):659-63.
|
|
|
|
|
124.
|
Musi N, Braverman LE, Norris CM. Severe thyrotoxicosis after parathyroid surgery for hyperparathyroidism. Am J Med. 2000 Apr 15; 108(6):519-20.
|
|
|
|
|
125.
|
Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab. 1999 Nov; 84(11):3877-85.
|
|
|
|
|
126.
|
Blüher M, Krohn K, Wallaschofski H, Braverman LE, Paschke R. Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats. Eur J Endocrinol. 1999 Nov; 141(5):506-11.
|
|
|
|
|
127.
|
Tang KT, Yang HJ, Choo KB, Lin HD, Fang SL, Braverman LE. A point mutation in the albumin gene in a Chinese patient with familial dysalbuminemic hyperthyroxinemia. Eur J Endocrinol. 1999 Oct; 141(4):374-8.
|
|
|
|
|
128.
|
Blüher M, Krohn K, Wallaschofski H, Braverman LE, Paschke R. Cytokine gene expression in autoimmune thyroiditis in BioBreeding/Worcester rats. Thyroid. 1999 Oct; 9(10):1049-55.
|
|
|
|
|
129.
|
Milne M, Kang MI, Cardona G, Quail JM, Braverman LE, Chin WW, Baran DT. Expression of multiple thyroid hormone receptor isoforms in rat femoral and vertebral bone and in bone marrow osteogenic cultures. J Cell Biochem. 1999 Sep 15; 74(4):684-93.
|
|
|
|
|
130.
|
Simkin PH, Ramirez LA, Zweizig SL, Afonso SA, Fraire AE, Khan A, Dunn AD, Dunn JT, Braverman LE. Monomorphic teratoma of the ovary: a rare cause of triiodothyronine toxicosis. Thyroid. 1999 Sep; 9(9):949-54.
|
|
|
|
|
131.
|
Colzani RM, Alex S, Dunn AD, Dunn JT, Stone S, Braverman LE. The oral administration of human thyroglobulin does not affect the incidence of lymphocytic thyroiditis in the biobreeding Worcester rat. Thyroid. 1999 Aug; 9(8):831-5.
|
|
|
|
|
132.
|
Mori K, Stone S, Khaodhiar L, Braverman LE, DeVito WJ. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. J Cell Biochem. 1999 Aug 1; 74(2):211-9.
|
|
|
|
|
133.
|
Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology. 1999 Aug; 140(8):3404-10.
|
|
|
|
|
134.
|
Braverman LE. Sidney C. Werner. 1909-1994. Proc Assoc Am Physicians. 1999 Jul-Aug; 111(4):369-70.
|
|
|
|
|
135.
|
Lawrence JE, Lamm SH, Braverman LE. The use of perchlorate for the prevention of thyrotoxicosis in patients given iodine rich contrast agents. J Endocrinol Invest. 1999 May; 22(5):405-7.
|
|
|
|
|
136.
|
Colzani RM, Alex S, Fang SL, Stone S, Braverman LE. Effects of iodine repletion on thyroid morphology in iodine and/or selenium deficient rat term fetuses, pups and mothers. Biochimie. 1999 May; 81(5):485-91.
|
|
|
|
|
137.
|
Lamm SH, Braverman LE, Li FX, Richman K, Pino S, Howearth G. Thyroid health status of ammonium perchlorate workers: a cross-sectional occupational health study. J Occup Environ Med. 1999 Apr; 41(4):248-60.
|
|
|
|
|
138.
|
Roti E, Gardini E, Magotti MG, Pilla S, Minelli R, Salvi M, Monica C, Maestri D, Cencetti S, Braverman LE. Are thyroid function tests too frequently and inappropriately requested? J Endocrinol Invest. 1999 Mar; 22(3):184-90.
|
|
|
|
|
139.
|
Braverman LE, Quilliam LA. Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck. J Biol Chem. 1999 Feb 26; 274(9):5542-9.
|
|
|
|
|
140.
|
Minelli R, Braverman LE, Valli MA, Schianchi C, Pedrazzoni M, Fiaccadori F, Salvi M, Magotti MG, Roti E. Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis. Clin Endocrinol (Oxf). 1999 Jan; 50(1):95-100.
|
|
|
|
|
141.
|
Braverman LE. Subclinical hypothyroidism and hyperthyroidism in elderly subjects: should they be treated? J Endocrinol Invest. 1999; 22(10 Suppl):1-3.
|
|
|
|
|
142.
|
Davies TF, Roti E, Braverman LE, DeGroot LJ. Thyroid controversy--stimulating antibodies. J Clin Endocrinol Metab. 1998 Nov; 83(11):3777-85.
|
|
|
|
|
143.
|
Mori K, Mori M, Stone S, Braverman LE, DeVito WJ. Increased expression of tumor necrosis factor-alpha and decreased expression of thyroglobulin and thyroid peroxidase mRNA levels in the thyroids of iodide-treated BB/Wor rats. Eur J Endocrinol. 1998 Nov; 139(5):539-45.
|
|
|
|
|
144.
|
Hollowell JG, Staehling NW, Hannon WH, Flanders DW, Gunter EW, Maberly GF, Braverman LE, Pino S, Miller DT, Garbe PL, DeLozier DM, Jackson RJ. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994) J Clin Endocrinol Metab. 1998 Oct; 83(10):3401-8.
|
|
|
|
|
145.
|
Liberman CS, Pino SC, Fang SL, Braverman LE, Emerson CH. Circulating iodide concentrations during and after pregnancy. J Clin Endocrinol Metab. 1998 Oct; 83(10):3545-9.
|
|
|
|
|
146.
|
Colzani RM, Alex S, Fang SL, Braverman LE, Emerson CH. The effect of recombinant human thyrotropin (rhTSH) on thyroid function in mice and rats. Thyroid. 1998 Sep; 8(9):797-801.
|
|
|
|
|
147.
|
Braverman LE. Adequate iodine intake--the good far outweighs the bad. Eur J Endocrinol. 1998 Jul; 139(1):14-5.
|
|
|
|
|
148.
|
Alex S, Braverman LE, Fang SL, Norvell B, Robinson S, Franz C, Longcope C. Dehydroepiandrosterone sulfate does not prevent spontaneous and iodine-induced lymphocytic thyroiditis and diabetes mellitus in the BB/Wor rat. Eur J Endocrinol. 1998 Jun; 138(6):719-23.
|
|
|
|
|
149.
|
Brown RS, Cohen JH, Braverman LE. Successful treatment of massive acute thyroid hormone poisoning with iopanoic acid. J Pediatr. 1998 May; 132(5):903-5.
|
|
|
|
|
150.
|
Braverman LE. Prevention of thyroid eye disease and final conclusions. Thyroid. 1998 May; 8(5):453.
|
|
|
|
|
151.
|
Colzani R, Fang SL, Alex S, Braverman LE. The effect of nicotine on thyroid function in rats. Metabolism. 1998 Feb; 47(2):154-7.
|
|
|
|
|
152.
|
Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid. 1998 Jan; 8(1):83-100.
|
|
|
|
|
153.
|
Baltz RH, Norris FH, Matsushima P, DeHoff BS, Rockey P, Porter G, Burgett S, Peery R, Hoskins J, Braverman L, Jenkins I, Solenberg P, Young M, McHenney MA, Skatrud PL, Rosteck PR. DNA sequence sampling of the Streptococcus pneumoniae genome to identify novel targets for antibiotic development. Microb Drug Resist. 1998; 4(1):1-9.
|
|
|
|
|
154.
|
Pino S, Fang SL, Braverman LE. Ammonium persulfate: a new and safe method for measuring urinary iodine by ammonium persulfate oxidation. Exp Clin Endocrinol Diabetes. 1998; 106 Suppl 3:S22-7.
|
|
|
|
|
155.
|
Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med. 1997 Sep 25; 337(13):888-96.
|
|
|
|
|
156.
|
Minelli R, Braverman LE, Giuberti T, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Roti E. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment. Clin Endocrinol (Oxf). 1997 Sep; 47(3):357-61.
|
|
|
|
|
157.
|
Ramirez L, Braverman LE, White B, Emerson CH. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab. 1997 Sep; 82(9):2836-9.
|
|
|
|
|
158.
|
Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman LE. Routine skin cleansing with povidone-iodine is not a common cause of transient neonatal hypothyroidism in North America: a prospective controlled study. Thyroid. 1997 Jun; 7(3):395-400.
|
|
|
|
|
159.
|
Suwanwalaikorn S, Van Auken M, Kang MI, Alex S, Braverman LE, Baran DT. Site selectivity of osteoblast gene expression response to thyroid hormone localized by in situ hybridization. Am J Physiol. 1997 Feb; 272(2 Pt 1):E212-7.
|
|
|
|
|
160.
|
Marinó M, Ricciardi R, Pinchera A, Barbesino G, Manetti L, Chiovato L, Braverman LE, Rossi B, Muratorio A, Mariotti S. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab. 1997 Feb; 82(2):438-43.
|
|
|
|
|
161.
|
Emerson CH, Colzani R, Braverman LE. Epithelial cell thyroid cancer and thyroid stimulating hormone--when less is more. J Clin Endocrinol Metab. 1997 Jan; 82(1):9-10.
|
|
|
|
|
162.
|
Kulkarni RS, Braverman LE, Patwardhan NA. Bilateral cervical plexus block for thyroidectomy and parathyroidectomy in healthy and high risk patients. J Endocrinol Invest. 1996 Dec; 19(11):714-8.
|
|
|
|
|
163.
|
Mori K, Stone S, Braverman LE, DeVito WJ. Effects of ceramide and protein kinase C on the regulation of type I 5'-deiodinase in FRTL-5 rat thyroid cells. Endocrinology. 1996 Nov; 137(11):4994-9.
|
|
|
|
|
164.
|
Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Neri TM, Braverman LE. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med. 1996 Nov; 101(5):482-7.
|
|
|
|
|
165.
|
Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med. 1996 Oct 28; 156(19):2165-72.
|
|
|
|
|
166.
|
Braverman LE. Is there one successful antithyroid regimen for Graves' disease? Lancet. 1996 Sep 14; 348(9029):697-8.
|
|
|
|
|
167.
|
Braverman L. The different faces of thyrotoxicosis. Cleve Clin J Med. 1996 Sep; 63(5):259-61.
|
|
|
|
|
168.
|
Farwell AP, Braverman LE. Inflammatory thyroid disorders. Otolaryngol Clin North Am. 1996 Aug; 29(4):541-56.
|
|
|
|
|
169.
|
Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab. 1996 Aug; 81(8):2976-9.
|
|
|
|
|
170.
|
Minelli R, Girasole G, Pedrazzoni M, Giuliani N, Schianchi C, Giuberti T, Braverman LE, Salvi M, Roti E. Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy. J Investig Med. 1996 Aug; 44(6):370-4.
|
|
|
|
|
171.
|
Veronikis IE, Simkin P, Braverman LE. Thymic uptake of iodine-131 in the anterior mediastinum. J Nucl Med. 1996 Jun; 37(6):991-2.
|
|
|
|
|
172.
|
Veronikis IE, Braverman LE, Alex S, Fang SL, Norvell B, Emerson CH. Comparison of the effects of propylthiouracil and selenium deficiency on T3 production in the rat. Endocrinology. 1996 Jun; 137(6):2580-5.
|
|
|
|
|
173.
|
Suwanwalaikorn S, Ongphiphadhanakul B, Braverman LE, Baran DT. Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats. Eur J Endocrinol. 1996 May; 134(5):655-9.
|
|
|
|
|
174.
|
Mori K, Stone S, Braverman LE, Devito WJ. Involvement of tyrosine phosphorylation in the regulation of 5'-deiodinases in FRTL-5 rat thyroid cells and rat astrocytes. Endocrinology. 1996 Apr; 137(4):1313-8.
|
|
|
|
|
175.
|
Veronikis IE, Alex S, Fang SL, Wright G, Wu SY, Chanoine JP, Emerson CH, Braverman LE. Serum iodothyronine concentrations in intestinally decontaminated rats treated with a 5'-deiodinase type I inhibitor 6-anilino-2-thiouracil. Eur J Endocrinol. 1996 Apr; 134(4):519-23.
|
|
|
|
|
176.
|
Tang KT, Capparelli C, Stein JL, Stein GS, Lian JB, Huber AC, Braverman LE, DeVito WJ. Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes. J Cell Biochem. 1996 Apr; 61(1):152-66.
|
|
|
|
|
177.
|
Pino S, Fang SL, Braverman LE. Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem. 1996 Feb; 42(2):239-43.
|
|
|
|
|
178.
|
Allen EM, Braverman LE. The biobreeding Worcester rat--a model of organ-specific autoimmunity. Exp Clin Endocrinol Diabetes. 1996; 104 Suppl 3:7-10.
|
|
|
|
|
179.
|
Braverman LE, Roti E. Effects of iodine on thyroid function. Acta Med Austriaca. 1996; 23(1-2):4-9.
|
|
|
|
|
180.
|
Mello CJ, Veronikis I, Fraire AE, Aronin N, Irwin RS, Braverman LE. Metastatic papillary thyroid carcinoma to lung diagnosed by bronchoalveolar lavage. J Clin Endocrinol Metab. 1996 Jan; 81(1):406-10.
|
|
|
|
|
181.
|
Braverman LE. Evaluation of thyroid status in patients with thyrotoxicosis. Clin Chem. 1996 Jan; 42(1):174-8.
|
|
|
|
|
182.
|
Oppenheimer JH, Braverman LE, Toft A, Jackson IM, Ladenson PW. A therapeutic controversy. Thyroid hormone treatment: when and what? J Clin Endocrinol Metab. 1995 Oct; 80(10):2873-83.
|
|
|
|
|
183.
|
Roti E, Bartalena L, Minelli R, Salvi M, Gardini E, Pistolesi A, Martino E, Braverman LE. Circadian thyrotropin variations are preserved in normal pregnant women. Eur J Endocrinol. 1995 Jul; 133(1):71-4.
|
|
|
|
|
184.
|
Patwardhan N, Cataldo T, Braverman LE. Surgical management of the patient with papillary cancer. Surg Clin North Am. 1995 Jun; 75(3):449-64.
|
|
|
|
|
185.
|
Braverman LE, Roti E. The role of iodine in the management of Graves' disease. Endocr Pract. 1995 May-Jun; 1(3):200-4.
|
|
|
|
|
186.
|
Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, Greenspan FS, McDougall IR, Nikolai TF. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995 Mar 8; 273(10):808-12.
|
|
|
|
|
187.
|
Tang KT, Braverman LE, DeVito WJ. Tumor necrosis factor-alpha and interferon-gamma modulate gene expression of type I 5'-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinology. 1995 Mar; 136(3):881-8.
|
|
|
|
|
188.
|
Martino E, Aghini-Lombardi F, Bartalena L, Grasso L, Loviselli A, Velluzzi F, Pinchera A, Braverman LE. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med. 1994 Dec 12-26; 154(23):2722-6.
|
|
|
|
|
189.
|
Tang KT, Braverman LE, DeVito WJ. Effects of fibroblast growth factor on type I 5'-deiodinase in FRTL-5 rat thyroid cells. Endocrinology. 1994 Aug; 135(2):493-500.
|
|
|
|
|
190.
|
Jenis LG, Ongphiphadhanakul B, Braverman LE, Stein GS, Lian JB, Lew R, Baran DT. Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo. Calcif Tissue Int. 1994 Jun; 54(6):511-5.
|
|
|
|
|
191.
|
Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, Braverman LE, Pinchera A. Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology. 1994 May; 134(5):2277-82.
|
|
|
|
|
192.
|
Ongphiphadhanakul B, Fang SL, Tang KT, Patwardhan NA, Braverman LE. Tumor necrosis factor-alpha decreases thyrotropin-induced 5'-deiodinase activity in FRTL-5 thyroid cells. Eur J Endocrinol. 1994 May; 130(5):502-7.
|
|
|
|
|
193.
|
Roti E, Bianconi L, De Chiara F, Minelli R, Tosi C, Gardini E, Salvi M, Braverman LE. Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis. J Endocrinol Invest. 1994 Apr; 17(4):259-62.
|
|
|
|
|
194.
|
Roti E, Minelli R, Gardini E, Bianconi L, Salvi M, Gavaruzzi G, Ugolotti G, Braverman LE. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease. J Clin Endocrinol Metab. 1994 Mar; 78(3):795-9.
|
|
|
|
|
195.
|
Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 1994 Feb; 78(2):423-7.
|
|
|
|
|
196.
|
Braverman LE. Deiodination of thyroid hormones. A 30 year perspective (Berthold Memorial Award Lecture 1994). Exp Clin Endocrinol. 1994; 102(5):355-63.
|
|
|
|
|
197.
|
Braverman LE. Iodine and the thyroid: 33 years of study. Thyroid. 1994; 4(3):351-6.
|
|
|
|
|
198.
|
Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M, DeGroot LJ, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab. 1994 Jan; 78(1):188-96.
|
|
|
|
|
199.
|
Ongphiphadhanakul B, Jenis LG, Braverman LE, Alex S, Stein GS, Lian JB, Baran DT. Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function. Endocrinology. 1993 Dec; 133(6):2502-7.
|
|
|
|
|
200.
|
Chanoine JP, Veronikis I, Alex S, Stone S, Fang SL, Leonard JL, Braverman LE. The postnatal serum 3,5,3'-triiodothyronine (T3) surge in the rat is largely independent of extrathyroidal 5'-deiodination of thyroxine to T3. Endocrinology. 1993 Dec; 133(6):2604-9.
|
|
|
|
|
201.
|
Patwardhan NA, Moront M, Rao S, Rossi S, Braverman LE. Surgery still has a role in Graves' hyperthyroidism. Surgery. 1993 Dec; 114(6):1108-12; discussion 1112-3.
|
|
|
|
|
202.
|
Aghini-Lombardi F, Mariotti S, Fosella PV, Grasso L, Pinchera A, Braverman LE, Martino E. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest. 1993 Nov; 16(10):823-6.
|
|
|
|
|
203.
|
Chanoine JP, Alex S, Stone S, Fang SL, Veronikis I, Leonard JL, Braverman LE. Placental 5-deiodinase activity and fetal thyroid hormone economy are unaffected by selenium deficiency in the rat. Pediatr Res. 1993 Sep; 34(3):288-92.
|
|
|
|
|
204.
|
Roti E, Minelli R, Gardini E, Braverman LE. The use and misuse of thyroid hormone. Endocr Rev. 1993 Aug; 14(4):401-23.
|
|
|
|
|
205.
|
Chanoine JP, Braverman LE, Farwell AP, Safran M, Alex S, Dubord S, Leonard JL. The thyroid gland is a major source of circulating T3 in the rat. J Clin Invest. 1993 Jun; 91(6):2709-13.
|
|
|
|
|
206.
|
Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch Intern Med. 1993 Apr 12; 153(7):886-92.
|
|
|
|
|
207.
|
Roti E, Gardini E, Minelli R, Bianconi L, Braverman LE. Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease. Metabolism. 1993 Apr; 42(4):403-8.
|
|
|
|
|
208.
|
Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. J Clin Endocrinol Metab. 1993 Apr; 76(4):928-32.
|
|
|
|
|
209.
|
Chanoine JP, Stein GS, Braverman LE, Shalhoub V, Lian JB, Huber CA, DeVito WJ. Acidic fibroblast growth factor modulates gene expression in the rat thyroid in vivo. J Cell Biochem. 1992 Dec; 50(4):392-9.
|
|
|
|
|
210.
|
Roti E, Minelli R, Gardini E, Bianconi L, Gavaruzzi G, Ugolotti G, Neri TM, Braverman LE. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 1992 Nov; 75(5):1273-7.
|
|
|
|
|
211.
|
Chanoine JP, Safran M, Farwell AP, Dubord S, Alex S, Stone S, Arthur JR, Braverman LE, Leonard JL. Effects of selenium deficiency on thyroid hormone economy in rats. Endocrinology. 1992 Oct; 131(4):1787-92.
|
|
|
|
|
212.
|
Ongphiphadhanakul B, Alex S, Braverman LE, Baran DT. Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin. J Bone Miner Res. 1992 Oct; 7(10):1227-31.
|
|
|
|
|
213.
|
De Vito WJ, Chanoine JP, Alex S, Fang SL, Stone S, Huber CA, Shalhoub V, Lian JB, Stein GS, Braverman LE. Effect of in vivo administration of recombinant acidic fibroblast growth factor on thyroid function in the rat: induction of colloid goiter. Endocrinology. 1992 Aug; 131(2):729-35.
|
|
|
|
|
214.
|
Ongphiphadhanakul B, Ebner SA, Fang SL, Lombardi A, Baran DT, Braverman LE. 1,25-Dihydroxycholecalciferol modulates 3H-thymidine incorporation in FRTL5 cells. J Cell Biochem. 1992 Jul; 49(3):304-9.
|
|
|
|
|
215.
|
Chanoine JP, Safran M, Farwell AP, Tranter P, Ekenbarger DM, Dubord S, Alex S, Arthur JR, Beckett GJ, Braverman LE, et al. Selenium deficiency and type II 5'-deiodinase regulation in the euthyroid and hypothyroid rat: evidence of a direct effect of thyroxine. Endocrinology. 1992 Jul; 131(1):479-84.
|
|
|
|
|
216.
|
Braverman LE, Pratt BM, Ebner S, Longcope C. Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey. J Clin Endocrinol Metab. 1992 May; 74(5):1135-9.
|
|
|
|
|
217.
|
Ebner SA, Badonnel MC, Altman LK, Braverman LE. Conjugal Graves disease. Ann Intern Med. 1992 Mar 15; 116(6):479-81.
|
|
|
|
|
218.
|
Chanoine JP, Alex S, Fang SL, Stone S, Leonard JL, Körhle J, Braverman LE. Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain. Endocrinology. 1992 Feb; 130(2):933-8.
|
|
|
|
|
219.
|
Roti E, Gardini E, Minelli R, Bianconi L, Braverman LE. Prevalence of anti-thyroid peroxidase antibodies in serum in the elderly: comparison with other tests for anti-thyroid antibodies. Clin Chem. 1992 Jan; 38(1):88-92.
|
|
|
|
|
220.
|
Ebner SA, Lueprasitsakul W, Alex S, Fang SL, Appel MC, Braverman LE. Iodine content of rat thyroglobulin affects its antigenicity in inducing lymphocytic thyroiditis in the BB/Wor rat. Autoimmunity. 1992; 13(3):209-14.
|
|
|
|
|
221.
|
Chanoine JP, Braverman LE. The role of transthyretin in the transport of thyroid hormone to cerebrospinal fluid and brain. Acta Med Austriaca. 1992; 19 Suppl 1:25-8.
|
|
|
|
|
222.
|
Roti E, Minelli R, Gardini E, Bianconi L, Neri T, Gavaruzzi G, Ugolotti G, Salvo D, Braverman LE. Impaired intrathyroidal iodine organification and iodine-induced hypothyroidism in euthyroid women with a previous episode of postpartum thyroiditis. J Clin Endocrinol Metab. 1991 Nov; 73(5):958-63.
|
|
|
|
|
223.
|
Martino E, Balzano S, Bartalena L, Loviselli A, Sica V, Petrini L, Grasso L, Piga M, Braverman LE. Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism. J Endocrinol Invest. 1991 Nov; 14(10):847-51.
|
|
|
|
|
224.
|
Abend SL, Fang SL, Alex S, Braverman LE, Leonard JL. Rapid alteration in circulating free thyroxine modulates pituitary type II 5' deiodinase and basal thyrotropin secretion in the rat. J Clin Invest. 1991 Sep; 88(3):898-903.
|
|
|
|
|
225.
|
Hollingsworth HM, Pratter MR, Dubois JM, Braverman LE, Irwin RS. Effect of triiodothyronine-induced thyrotoxicosis on airway hyperresponsiveness. J Appl Physiol. 1991 Aug; 71(2):438-44.
|
|
|
|
|
226.
|
Baran DT, Braverman LE. Thyroid hormones and bone mass. J Clin Endocrinol Metab. 1991 Jun; 72(6):1182-3.
|
|
|
|
|
227.
|
Lueprasitsakul W, Fang SL, Alex S, Braverman LE. Effect of the cardiac inotropic drug, OPC 8212, on pituitary-thyroid function in the rat. Endocrinology. 1991 Jun; 128(6):2709-14.
|
|
|
|
|
228.
|
Roti E, Gardini E, Minelli R, Bianconi L, Pino S, Braverman LE. Iodine prophylaxis in schoolchildren residing in the province of Parma, Italy. J Endocrinol Invest. 1991 May; 14(5):417-8.
|
|
|
|
|
229.
|
Braverman LE. Effects of iodine on thyroid function in man. Trans Am Clin Climatol Assoc. 1991; 102:143-51; discussion 151-2.
|
|
|
|
|
230.
|
Hintze G, Braverman LE, Ingbar SH. The effect of surgical stress on the in vitro metabolism of thyroxine by rat liver, kidney, and brain. Endocrinology. 1991 Jan; 128(1):146-52.
|
|
|
|
|
231.
|
Rajatanavin R, Appel MC, Reinhardt W, Alex S, Yang YN, Braverman LE. Variable prevalence of lymphocytic thyroiditis among diabetes-prone sublines of BB/W or rats. Endocrinology. 1991 Jan; 128(1):153-7.
|
|
|
|
|
232.
|
Emerson CH, Braverman LE. Transfer and metabolism of thyroid-related substances in the placenta. Adv Exp Med Biol. 1991; 299:181-96.
|
|
|
|
|
233.
|
Huber AC, Van Zwieten MJ, DeVito WJ, Braverman LE. The daily intravenous administration of acidic fibroblast growth factor induces goiter in rats. Trans Assoc Am Physicians. 1991; 104:273-7.
|
|
|
|
|
234.
|
Lueprasitsakul W, Alex S, Fang SL, Appel MC, Braverman LE. Thyroglobulin induced lymphocytic thyroiditis in two sublines of BB/Wor rats. Autoimmunity. 1991; 9(1):55-60.
|
|
|
|
|
235.
|
Allen EM, Braverman LE. The effect of iodine on lymphocytic thyroiditis in the thymectomized buffalo rat. Endocrinology. 1990 Oct; 127(4):1613-6.
|
|
|
|
|
236.
|
Lueprasitsakul W, Abend S, Alex S, Reinhardt W, Appel MC, Braverman LE. Effect of thalidomide on the incidence of iodine-induced and spontaneous lymphocytic thyroiditis and spontaneous diabetes mellitus in the BB/Wor rat. Acta Endocrinol (Copenh). 1990 Jul; 123(1):79-83.
|
|
|
|
|
237.
|
Simons RJ, Manni A, Fang SL, Braverman L. Free triiodothyronine toxicosis in a patient with multinodular goiter. Am J Med. 1990 Jun; 88(6):689-92.
|
|
|
|
|
238.
|
Lueprasitsakul W, Alex S, Fang SL, Pino S, Irmscher K, Köhrle J, Braverman LE. Flavonoid administration immediately displaces thyroxine (T4) from serum transthyretin, increases serum free T4, and decreases serum thyrotropin in the rat. Endocrinology. 1990 Jun; 126(6):2890-5.
|
|
|
|
|
239.
|
Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE. Iodine-induced hypothyroidism in euthyroid subjects with a previous episode of subacute thyroiditis. J Clin Endocrinol Metab. 1990 Jun; 70(6):1581-5.
|
|
|
|
|
240.
|
De Bruin TW, Braverman LE, Brown RS. Heterogeneity of TSH receptor-binding antibodies in Hashimoto's thyroiditis and Graves' disease. Am J Med Sci. 1990 May; 299(5):291-7.
|
|
|
|
|
241.
|
Abend S, Cormier J, Appel MC, Lueprasitsakul W, Alex S, Mordes JP, Usadel KH, Handler ES, Rossini AA, Braverman LE. The effect of ciamexone on lymphocytic thyroiditis and insulin-dependent diabetes mellitus in the BB/Wor rat. Immunopharmacology. 1990 May-Jun; 19(3):163-8.
|
|
|
|
|
242.
|
Longcope C, Abend S, Braverman LE, Emerson CH. Androstenedione and estrone dynamics in hypothyroid women. J Clin Endocrinol Metab. 1990 Apr; 70(4):903-7.
|
|
|
|
|
243.
|
Roti E, Gardini E, Minelli R, Bianconi L, Alboni A, Braverman LE. Thyrotropin releasing hormone does not stimulate prolactin release in the preterm human fetus. Acta Endocrinol (Copenh). 1990 Apr; 122(4):462-6.
|
|
|
|
|
244.
|
Farwell AP, Abend SL, Huang SK, Patwardhan NA, Braverman LE. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA. 1990 Mar 16; 263(11):1526-8.
|
|
|
|
|
245.
|
Safran M, Köhrle J, Braverman LE, Leonard JL. Effect of biological alterations of type I 5'deiodinase activity on affinity labeled membrane proteins in rat liver and kidney. Endocrinology. 1990 Feb; 126(2):826-31.
|
|
|
|
|
246.
|
Roti E, Minelli R, Gardini E, Salvi M, Bianconi L, Balducci L, Manfredi A, Braverman LE. Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis. J Endocrinol Invest. 1990 Jan; 13(1):69-72.
|
|
|
|
|
247.
|
Braverman LE. Iodine induced thyroid disease. Acta Med Austriaca. 1990; 17 Suppl 1:29-33.
|
|
|
|
|
248.
|
Braverman LE. Thyroid hormone deiodination. Thyroid. 1990; 1(1):49-51.
|
|
|
|
|
249.
|
Braverman LE. Integrity in submitting manuscripts. J Clin Endocrinol Metab. 1989 Dec; 69(6):i.
|
|
|
|
|
250.
|
Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, Doppman JL, Emerson CH, Braverman LE, Oldfield EH, Weintraub BD. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med. 1989 Nov 15; 111(10):827-35.
|
|
|
|
|
251.
|
Salvi M, Gardini E, Minelli R, Bianconi L, Pino S, Braverman LE, Roti E. Iodine deficiency in schoolchildren of the province of Parma, Italy. J Endocrinol Invest. 1989 Oct; 12(9):651-2.
|
|
|
|
|
252.
|
Reinhardt W, Appel MC, Alex S, Yang YN, Braverman LE. The inhibitory effect of large doses of methimazole on iodine induced lymphocytic thyroiditis and serum anti-thyroglobulin antibody titers in BB/Wor rats. J Endocrinol Invest. 1989 Sep; 12(8):559-63.
|
|
|
|
|
253.
|
Lombardi A, Tramontano D, Braverman LE, Ingbar SH. Transferrin in FRTL5 cells: regulation of its receptor by mitogenic agents and its role in growth. Endocrinology. 1989 Aug; 125(2):652-8.
|
|
|
|
|
254.
|
Roti E, Gardini E, Minelli R, Salvi M, Robuschi G, Braverman LE. Methimazole and serum thyroid hormone concentrations in hyperthyroid patients: effects of single and multiple daily doses. Ann Intern Med. 1989 Jul 15; 111(2):181-2.
|
|
|
|
|
255.
|
Köhrle J, Fang SL, Yang Y, Irmscher K, Hesch RD, Pino S, Alex S, Braverman LE. Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinology. 1989 Jul; 125(1):532-7.
|
|
|
|
|
256.
|
Cohen JH, Alex S, DeVito WJ, Braverman LE, Emerson CH. Fasting-associated changes in serum thyrotropin in the rat are influenced by gender. Endocrinology. 1989 Jun; 124(6):3025-9.
|
|
|
|
|
257.
|
Braverman LE. In memoriam Sidney H. Ingbar. Endocrinology. 1989 Jun; 124(6):3137-8.
|
|
|
|
|
258.
|
Cohen JH, Ingbar SH, Braverman LE. Thyrotoxicosis due to ingestion of excess thyroid hormone. Endocr Rev. 1989 May; 10(2):113-24.
|
|
|
|
|
259.
|
Emerson CH, Lew R, Braverman LE, DeVito WJ. Serum thyrotropin concentrations are more highly correlated with serum triiodothyronine concentrations than with serum thyroxine concentrations in thyroid hormone-infused thyroidectomized rats. Endocrinology. 1989 May; 124(5):2415-8.
|
|
|
|
|
260.
|
Rajatanavin R, Fang SL, Pino S, Laurberg P, Braverman LE, Smith M, Bullock LP. Thyroid hormone antibodies and Hashimoto's thyroiditis in mongrel dogs. Endocrinology. 1989 May; 124(5):2535-40.
|
|
|
|
|
261.
|
Martino E, Bartalena L, Mariotti S, Aghini-Lombardi F, Ceccarelli C, Lippi F, Piga M, Loviselli A, Braverman L, Safran M, et al. Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction. Acta Endocrinol (Copenh). 1988 Oct; 119(2):167-73.
|
|
|
|
|
262.
|
Roti E, Montermini M, Roti S, Gardini E, Robuschi G, Minelli R, Salvi M, Bentivoglio M, Guiducci U, Braverman LE. The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. Arch Intern Med. 1988 Sep; 148(9):1919-21.
|
|
|
|
|
263.
|
Safran M, Martino E, Aghini-Lombardi F, Bartalena L, Balzano S, Pinchera A, Braverman LE. Effect of amiodarone on circulating antithyroid antibodies. BMJ. 1988 Aug 13; 297(6646):456-7.
|
|
|
|
|
264.
|
Paul TL, Kerrigan J, Kelly AM, Braverman LE, Baran DT. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA. 1988 Jun 3; 259(21):3137-41.
|
|
|
|
|
265.
|
De Bruin TW, Patwardhan NA, Brown RS, Braverman LE. Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy. Clin Exp Immunol. 1988 Jun; 72(3):481-5.
|
|
|
|
|
266.
|
Young RA, Meyers B, Alex S, Fang SL, Braverman LE. Thyroxine binding to serum thyronine-binding globulin in thyroidectomized adult and normal neonatal rats. Endocrinology. 1988 May; 122(5):2318-23.
|
|
|
|
|
267.
|
Reinhardt W, Braverman LE, Safran M. [Effects of long-term administration of an iodine-containing mouthwash on iodine uptake and thyroid function]. Med Klin (Munich). 1988 Apr 15; 83(8-9):294-5, 312.
|
|
|
|
|
268.
|
Piga M, Bartalena L, Mariotti S, Aghini-Lombardi F, Ceccarelli C, Lippi F, Loviselli A, Braverman L, Safran M, Pinchera A, et al. [Thyroid uptake of I131 in iodine-induced thyroid pathology caused by amiodarone]. Recenti Prog Med. 1988 Apr; 79(4):151-5.
|
|
|
|
|
269.
|
Reinhardt W, Paul TL, Allen EM, Alex S, Yang YN, Appel MC, Braverman LE. Effect of L-thyroxine administration on the incidence of iodine induced and spontaneous lymphocytic thyroiditis in the BB/Wor rat. Endocrinology. 1988 Mar; 122(3):1179-81.
|
|
|
|
|
270.
|
Emerson CH, Bambini G, Alex S, Castro MI, Roti E, Braverman LE. The effect of thyroid dysfunction and fasting on placenta inner ring deiodinase activity in the rat. Endocrinology. 1988 Mar; 122(3):809-16.
|
|
|
|
|
271.
|
Ader AW, Paul TL, Reinhardt W, Safran M, Pino S, McArthur W, Braverman LE. Effect of mouth rinsing with two polyvinylpyrrolidone-iodine mixtures on iodine absorption and thyroid function. J Clin Endocrinol Metab. 1988 Mar; 66(3):632-5.
|
|
|
|
|
272.
|
Roti E, Robuschi G, Gardini E, Montermini M, Salvi M, Manfredi A, Gnudi A, Braverman LE. Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease. Clin Endocrinol (Oxf). 1988 Mar; 28(3):305-14.
|
|
|
|
|
273.
|
Paul T, Meyers B, Witorsch RJ, Pino S, Chipkin S, Ingbar SH, Braverman LE. The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism. 1988 Feb; 37(2):121-4.
|
|
|
|
|
274.
|
Allen EM, Braverman LE. Management of thyrotoxicosis. Compr Ther. 1987 Dec; 13(12):20-30.
|
|
|
|
|
275.
|
Gardner DF, Utiger RD, Schwartz SL, Witorsch P, Meyers B, Braverman LE, Witorsch RJ. Effects of oral erythrosine (2',4',5',7'-tetraiodofluorescein) on thyroid function in normal men. Toxicol Appl Pharmacol. 1987 Dec; 91(3):299-304.
|
|
|
|
|
276.
|
DeCosimo DR, Fang SL, Braverman LE. Prevalence of familial dysalbuminemic hyperthyroxinemia in Hispanics. Ann Intern Med. 1987 Nov; 107(5):780-1.
|
|
|
|
|
277.
|
Bambini G, Aghini-Lombardi F, Rosner W, Khan MS, Martino E, Pinchera A, Braverman LE, Safran M. Serum sex hormone-binding globulin in amiodarone-treated patients. A marker for tissue thyrotoxicosis. Arch Intern Med. 1987 Oct; 147(10):1781-5.
|
|
|
|
|
278.
|
Allen EM, Appel MC, Braverman LE. Iodine-induced thyroiditis and hypothyroidism in the hemithyroidectomized BB/W rat. Endocrinology. 1987 Aug; 121(2):481-5.
|
|
|
|
|
279.
|
Longcope C, Yosha S, Young RA, Baker S, Braverman LE. The effects of low-protein diet and testosterone on sex hormone-binding globulin capacity in male rabbits. Metabolism. 1987 Jul; 36(7):703-7.
|
|
|
|
|
280.
|
Safran M, Paul TL, Roti E, Braverman LE. Environmental factors affecting autoimmune thyroid disease. Endocrinol Metab Clin North Am. 1987 Jun; 16(2):327-42.
|
|
|
|
|
281.
|
Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E. Hypothyroidism in the elderly. Endocr Rev. 1987 May; 8(2):142-53.
|
|
|
|
|
282.
|
Robuschi G, Montermini M, Alboni A, Borciani E, Cersosimo G, Negrotti L, Gnudi A, Safran M, Braverman LE, Roti E. Cord blood iodothyronine and thyrotropin concentrations in newborns of mothers exposed to povidone iodine in the last trimester. J Endocrinol Invest. 1987 Apr; 10(2):183-6.
|
|
|
|
|
283.
|
Yeo PP, Yabu Y, Etzkorn JR, Rajatanavin R, Braverman LE, Ingbar SH. A four generation study of familial dysalbuminemic hyperthyroxinemia: diagnosis in the presence of an acquired excess of thyroxine-binding globulin. J Endocrinol Invest. 1987 Feb; 10(1):33-8.
|
|
|
|
|
284.
|
Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Lenziardi M, Ceccarelli C, Bambini G, Safran M, Braverman LE, Pinchera A. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol (Oxf). 1987 Feb; 26(2):227-37.
|
|
|
|
|
285.
|
Young RA, Stoffer SS, Braverman LE. Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease. Am J Med. 1987 Feb; 82(2):221-3.
|
|
|
|
|
286.
|
Braverman LE, Paul T, Reinhardt W, Appel MC, Allen EM. Effect of iodine intake and methimazole on lymphocytic thyroiditis in the BB/W rat. Acta Endocrinol Suppl (Copenh). 1987; 281:70-6.
|
|
|
|
|
287.
|
Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Braverman L, Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res. 1987; 26(1-4):158-71.
|
|
|
|
|
288.
|
De Bruin TW, Braverman LE, Brown RS. Further evaluation of an immunoprecipitation assay for TSH-receptor autoantibodies in Graves' disease. Metabolism. 1986 Dec; 35(12):1101-5.
|
|
|
|
|
289.
|
Martino E, Mariotti S, Aghini-Lombardi F, Lenziardi M, Morabito S, Baschieri L, Pinchera A, Braverman L, Safran M. Short term administration of potassium perchlorate restores euthyroidism in amiodarone iodine-induced hypothyroidism. J Clin Endocrinol Metab. 1986 Nov; 63(5):1233-6.
|
|
|
|
|
290.
|
Allen EM, Rajatanavin R, Nogimori T, Cushing G, Ingbar SH, Braverman LE. The effect of methimazole on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Am J Med Sci. 1986 Nov; 292(5):267-71.
|
|
|
|
|
291.
|
Robuschi G, Montermini M, Gardini E, Salvi M, Braverman LE, Gnudi A, Roti E. Unusual association of medullary carcinoma and toxic adenoma of the thyroid. J Nucl Med Allied Sci. 1986 Oct-Dec; 30(4):231-4.
|
|
|
|
|
292.
|
Young RA, Rajatanavin R, Braverman LE, Tennant BC. Seasonal changes in serum thyroid hormone binding proteins in the woodchuck (Marmota monax). Endocrinology. 1986 Sep; 119(3):967-71.
|
|
|
|
|
293.
|
Safran M, Fang SL, Bambini G, Pinchera A, Martino E, Braverman LE. Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat. Am J Med Sci. 1986 Sep; 292(3):136-41.
|
|
|
|
|
294.
|
Martino E, Aghini-Lombardi F, Mariotti S, Lenziardi M, Baschieri L, Braverman LE, Pinchera A. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest. 1986 Jun; 9(3):201-7.
|
|
|
|
|
295.
|
Allen EM, Appel MC, Braverman LE. The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Endocrinology. 1986 May; 118(5):1977-81.
|
|
|
|
|
296.
|
Roti E, Braverman LE, Robuschi G, Salvi M, Gardini E, d'Amato L, Maestri D, Montermini M, Borciani E, Pezzarossa A, et al. Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients. Metabolism. 1986 Apr; 35(4):337-42.
|
|
|
|
|
297.
|
Skiest D, Braverman LE, Emerson CH. Concentration of free thyroxin in serum of a patient with euthyroid hyperthyroxinemia secondary to increased thyroxin-binding prealbumin: results by various methods compared. Clin Chem. 1986 Apr; 32(4):687-9.
|
|
|
|
|
298.
|
Nogimori T, Braverman LE, Taurog A, Fang SL, Wright G, Emerson CH. A new class of propylthiouracil analogs: comparison of 5'-deiodinase inhibition and antithyroid activity. Endocrinology. 1986 Apr; 118(4):1598-605.
|
|
|
|
|
299.
|
Frey H, Skare S, Sand T, Siersbaek-Nielsen K, Meyers B, Young R, Braverman L, Nyhus S. [Familial dysalbuminemic hyperthyroxinemia]. Tidsskr Nor Laegeforen. 1986 Mar 20; 106(8):659-62.
|
|
|
|
|
300.
|
Castro MI, Alex S, Young RA, Braverman LE, Emerson CH. Total and free serum thyroid hormone concentrations in fetal and adult pregnant and nonpregnant guinea pigs. Endocrinology. 1986 Feb; 118(2):533-7.
|
|
|
|
|
301.
|
Evans RW, Braverman LE. Use of 125I-triiodothyroacetic acid to measure nuclear thyroid hormone receptor. Endocr Res. 1986; 12(1):37-47.
|
|
|
|
|
302.
|
degli Uberti EC, Roti E, Trasforini G, Salvadori S, Margutti A, Robuschi G, Tomatis R, Gnudi A, Pansini R, Braverman LE. Somatostatin inhibits the dermorphin-stimulated thyrotropin release in man. Horm Res. 1986; 23(4):207-12.
|
|
|
|
|
303.
|
Martino E, Aghini-Lombardi F, Lippi F, Baschieri L, Safran M, Braverman LE, Pinchera A. Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis. J Nucl Med. 1985 Dec; 26(12):1402-7.
|
|
|
|
|
304.
|
Nogimori T, Emerson CH, Braverman LE, Wu CF, Gambino J, Wright GE. Synthesis of 6-anilino-2-thiouracils and their inhibition of human placenta iodothyronine deiodinase. J Med Chem. 1985 Nov; 28(11):1692-4.
|
|
|
|
|
305.
|
Castro MI, Braverman LE, Alex S, Wu CF, Emerson CH. Inner-ring deiodination of 3,5,3'-triiodothyronine in the in situ perfused guinea pig placenta. J Clin Invest. 1985 Nov; 76(5):1921-6.
|
|
|
|
|
306.
|
Coslovsky R, Braverman LE, Leeman SE, Aronin N. The differential effects of thyroid and gonadal hormones on substance P content in the anterior pituitary of the prepubertal rat. Endocrinology. 1985 Nov; 117(5):2198-202.
|
|
|
|
|
307.
|
Braverman L. The phenomenon of teenage marriage. Semin Adolesc Med. 1985 Sep; 1(3):189-94.
|
|
|
|
|
308.
|
Irwin RS, Pratter MR, Stivers DH, Braverman LE. Airway reactivity and lung function in triiodothyronine-induced thyrotoxicosis. J Appl Physiol. 1985 May; 58(5):1485-8.
|
|
|
|
|
309.
|
Roti E, Robuschi G, Manfredi A, D'Amato L, Gardini E, Salvi M, Montermini M, Barlli AL, Gnudi A, Braverman LE. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. Clin Endocrinol (Oxf). 1985 Apr; 22(4):489-96.
|
|
|
|
|
310.
|
Young RA, Rajatanavin R, Moring AF, Braverman LE. Fasting induces the generation of serum thyronine-binding globulin in Zucker rats. Endocrinology. 1985 Apr; 116(4):1248-52.
|
|
|
|
|
311.
|
Safran M, Braverman LE. Thyrotoxicosis and Graves disease. Hosp Pract (Off Ed). 1985 Mar 30; 20(3A):33-42, 46-9.
|
|
|
|
|
312.
|
Yabu Y, Amir SM, Ruiz M, Braverman LE, Ingbar SH. Heterogeneity of thyroxine binding by serum albumins in normal subjects and patients with familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 1985 Mar; 60(3):451-9.
|
|
|
|
|
313.
|
Robuschi G, Braverman LE, Emanuele R, d'Amato L, Gardini E, Foscolo MS, Gualerzi C, Benassi L, Gnudi A, Roti E. Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone. J Perinat Med. 1985; 13(5):219-26.
|
|
|
|
|
314.
|
Martino E, Aghini-Lombardi F, Lippi F, Lenziardi M, Capellini Q, Safran M, Braverman LE, Baschieri L, Pinchera A. [Thyroid uptake of 131I in different forms of hyperthyroidism caused by amiodarone]. Minerva Endocrinol. 1985 Jan-Mar; 10(1):1-10.
|
|
|
|
|
315.
|
Coslovsky R, Evans RW, Leeman SE, Braverman LE, Aronin N. The effects of gonadal steroids on the content of substance P in the rat anterior pituitary. Endocrinology. 1984 Dec; 115(6):2285-9.
|
|
|
|
|
316.
|
Yosha S, Longcope C, Braverman LE. The effect of D- and L-thyroxine on sex hormone-binding globulin in rabbits. Endocrinology. 1984 Oct; 115(4):1446-50.
|
|
|
|
|
317.
|
Yosha S, Fay M, Longcope C, Braverman LE. Effect of D-thyroxine on serum sex hormone binding globulin (SHBG), testosterone, and pituitary-thyroid function in euthyroid subjects. J Endocrinol Invest. 1984 Oct; 7(5):489-94.
|
|
|
|
|
318.
|
Becker DV, Braverman LE, Dunn JT, Gaitan E, Gorman C, Maxon H, Schneider AB, Van Middlesworth L, Wolff J. The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association. JAMA. 1984 Aug 3; 252(5):659-61.
|
|
|
|
|
319.
|
Rajatanavin R, Safran M, Stoller WA, Mordes JP, Braverman LE. Five patients with iodine-induced hyperthyroidism. Am J Med. 1984 Aug; 77(2):378-84.
|
|
|
|
|
320.
|
Blume FD, Boyer SJ, Braverman LE, Cohen A, Dirkse J, Mordes JP. Impaired osmoregulation at high altitude. Studies on Mt Everest. JAMA. 1984 Jul 27; 252(4):524-6.
|
|
|
|
|
321.
|
Roti E, Robuschi G, Alboni A, Emanuele R, d'Amato L, Gardini E, Salvi M, Dall'Aglio E, Gnudi A, Braverman LE. Inhibition of foetal growth hormone (GH) and thyrotrophin (TSH) secretion after maternal administration of somatostatin. Acta Endocrinol (Copenh). 1984 Jul; 106(3):393-9.
|
|
|
|
|
322.
|
Aronin N, Morency K, Leeman SE, Braverman LE, Coslovsky R. Regulation by thyroid hormone of the concentration of substance P in the rat anterior pituitary. Endocrinology. 1984 Jun; 114(6):2138-42.
|
|
|
|
|
323.
|
Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab. 1984 May; 58(5):868-72.
|
|
|
|
|
324.
|
Young RA, Fang SL, Prosky J, Braverman LE. Hepatic conversion of thyroxine to triiodothyronine in obese and lean Zucker rats. Life Sci. 1984 Apr 30; 34(18):1783-90.
|
|
|
|
|
325.
|
Fay M, Roti E, Fang SL, Wright G, Braverman LE, Emerson CH. The effects of propylthiouracil, iodothyronines, and other agents on thyroid hormone metabolism in human placenta. J Clin Endocrinol Metab. 1984 Feb; 58(2):280-6.
|
|
|
|
|
326.
|
Rajatanavin R, Young RA, Braverman LE. Effect of chloride on serum thyroxine binding in familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab. 1984 Feb; 58(2):388-91.
|
|
|
|
|
327.
|
Emerson CH, Braverman LE. Peripheral deiodination of thyroid hormones in placenta and fetal membranes. Horm Metab Res Suppl. 1984; 14:56-62.
|
|
|
|
|
328.
|
Roti E, Fang SL, Green K, Braverman LE, Emerson CH. Inner ring deiodination of thyroxine and 3,5,3'-triiodothyronine by human fetal membranes. Am J Obstet Gynecol. 1983 Dec 1; 147(7):788-92.
|
|
|
|
|
329.
|
Rajatanavin R, Braverman LE. Euthyroid hyperthyroxinemia. J Endocrinol Invest. 1983 Dec; 6(6):493-505.
|
|
|
|
|
330.
|
Evans RW, Farwell AP, Braverman LE. Nuclear thyroid hormone receptor in the rat uterus. Endocrinology. 1983 Oct; 113(4):1459-63.
|
|
|
|
|
331.
|
Cukor G, Blacklow NR, Nowak NA, Rich CM, Braverman LE, Fischer RA. Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients. J Clin Microbiol. 1983 Sep; 18(3):457-62.
|
|
|
|
|
332.
|
Shulkin BL, Utiger RD, Emerson CH, Braverman LE, Fay M. Preincubation of thyroxine with sulfhydryl-reducing agents does not stimulate thyroxine inner or outer ring deiodination. Endocrinology. 1983 Sep; 113(3):851-4.
|
|
|
|
|
333.
|
Young RA, Rajatanavin R, Braverman LE. Age affects the generation of serum thyronine-binding protein by rats fed a low protein-high carbohydrate diet. Endocrinology. 1983 Jul; 113(1):306-8.
|
|
|
|
|
334.
|
Mordes JP, Blume FD, Boyer S, Zheng MR, Braverman LE. High-altitude pituitary-thyroid dysfunction on Mount Everest. N Engl J Med. 1983 May 12; 308(19):1135-8.
|
|
|
|
|
335.
|
Roti E, Robuschi G, Emanuele R, d'Amato L, Gnudi A, Fatone M, Benassi L, Foscolo MS, Gualerzi C, Braverman LE. Failure of metoclopramide to affect thyrotropin concentration in the term human fetus. J Clin Endocrinol Metab. 1983 May; 56(5):1071-5.
|
|
|
|
|
336.
|
Roti E, Gnudi A, Braverman LE. The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev. 1983; 4(2):131-49.
|
|
|
|
|
337.
|
Rajatanavin R, Fournier L, DeCosimo D, Abreau C, Braverman LE. Elevated serum free thyroxine by thyroxine analog radioimmunoassays in euthyroid patients with familial dysalbuminemic hyperthyroxinemia. Ann Intern Med. 1982 Dec; 97(6):865-6.
|
|
|
|
|
338.
|
Roti E, Braverman LE, Fang SL, Alex S, Emerson CH. Ontogenesis of placental inner ring thyroxine deiodinase and amniotic fluid 3,3',5'-triiodothyronine concentration in the rat. Endocrinology. 1982 Sep; 111(3):959-63.
|
|
|
|
|
339.
|
Rajatanavian R, Fournier L, Abreau CM, Braverman LE. Free thyroxine RIA concentration (gammacoat) is spuriously elevated in blood collected in silicon-coated vacutainer tubes. J Nucl Med. 1982 Aug; 23(8):751-2.
|
|
|
|
|
340.
|
Eastwood GL, Braverman LE, White EM, Vander Salm TJ. Reversal of lower esophageal sphincter hypotension and esophageal aperistalsis after treatment for hypothyroidism. J Clin Gastroenterol. 1982 Aug; 4(4):307-10.
|
|
|
|
|
341.
|
Safran M, Braverman LE. Effect of chronic douching with polyvinylpyrrolidone-iodine on iodine absorption and thyroid function. Obstet Gynecol. 1982 Jul; 60(1):35-40.
|
|
|
|
|
342.
|
Roti E, Gnudi A, Robuschi G, Emanuele R, Benassi L, Braverman LE. Response of growth hormone to thyrotropin-releasing hormone during fetal life. J Clin Endocrinol Metab. 1982 Jun; 54(6):1255-7.
|
|
|
|
|
343.
|
Young RA, Braverman LE, Rajatanavin R. Low protein-high carbohydrate diet induces alterations in the serum thyronine-binding proteins in the rat. Endocrinology. 1982 May; 110(5):1607-12.
|
|
|
|
|
344.
|
Ruiz M, Rajatanavin R, Young RA, Taylor C, Brown R, Braverman LE, Ingbar SH. Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis. N Engl J Med. 1982 Mar 18; 306(11):635-9.
|
|
|
|
|
345.
|
Ingbar JC, Borges M, Iflah S, Kleinmann RE, Braverman LE, Ingbar SH. Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine. J Endocrinol Invest. 1982 Mar-Apr; 5(2):77-85.
|
|
|
|
|
346.
|
Kleinmann RE, Sternthal E, Starobin O, Braverman LE. Cardiac catheterization dye does not affect serum thyroid hormone concentrations or TSH secretion. Cathet Cardiovasc Diagn. 1982; 8(3):261-5.
|
|
|
|
|
347.
|
Roti E, Fang SL, Braverman LE, Emerson CH. Rat placenta is an active site of inner ring deiodination of thyroxine and 3,3',5-triiodothyronine. Endocrinology. 1982 Jan; 110(1):34-7.
|
|
|
|
|
348.
|
Cukor G, Blacklow NR, Braverman LE. Antibodies to gastroenteritis viruses in cystic fibrosis patients. J Med Virol. 1982; 9(3):161-4.
|
|
|
|
|
349.
|
Sternthal E, Like AA, Sarantis K, Braverman LE. Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes. 1981 Dec; 30(12):1058-61.
|
|
|
|
|
350.
|
Emerson CH, Alex S, Braverman LE, Safran MS. A study of the effect of the thyrotropin-releasing hormone metabolite, histidyl-proline diketopiperazine, on prolactin secretion in vivo. Endocrinology. 1981 Nov; 109(5):1375-9.
|
|
|
|
|
351.
|
Roti E, Gnudi A, Braverman LE, Robuschi G, Emanuele R, Bandini P, Benassi L, Pagliani A, Emerson CH. Human cord blood concentrations of thyrotropin, thyroglobulin, and iodothyronines after maternal administration of thyrotropin-releasing hormone. J Clin Endocrinol Metab. 1981 Oct; 53(4):813-7.
|
|
|
|
|
352.
|
Roti E, Fang SL, Green K, Emerson CH, Braverman LE. Human placenta is an active site of thyroxine and 3,3'5-triiodothyronine tyrosyl ring deiodination. J Clin Endocrinol Metab. 1981 Sep; 53(3):498-501.
|
|
|
|
|
353.
|
Thompson ME, Greer MA, Braverman LE, Vagenakis AG. Evidence that regulation of thyrotropin secretion by the heterotopic pituitary is independent of endogenous thyrotropin-releasing hormone from any source. Proc Soc Exp Biol Med. 1981 Jun; 167(2):297-9.
|
|
|
|
|
354.
|
Coiro V, Frick GP, Braverman LE, Goodman HM. Effects of hypophysectomy and thyroidectomy on leucine metabolism in adipose tissue. Am J Physiol. 1981 Jun; 240(6):E669-76.
|
|
|
|
|
355.
|
Kapen S, Sternthal E, Braverman L. A "pubertal" 24-hour luteinizing hormone (LH) secretory pattern following weight loss in the absence of anorexia nervosa. Psychosom Med. 1981 Apr; 43(2):177-82.
|
|
|
|
|
356.
|
El-Zaheri MM, Vagenakis AG, Hinerfeld L, Emerson CH, Braverman LE. Maternal thyroid function is the major determinant of amniotic fluid 3,3',5'-triiodothyronine in the rat. J Clin Invest. 1981 Apr; 67(4):1126-33.
|
|
|
|
|
357.
|
Christianson D, Roti E, Vagenakis AG, Braverman LE. The sex-related difference in serum thyrotropin concentration is androgen mediated. Endocrinology. 1981 Feb; 108(2):529-35.
|
|
|
|
|
358.
|
Segall-Blank M, Vagenakis AG, Shwachman H, Ingbar SH, Braverman LE. Thyroid gland function and pituitary TSH reserve in patients with cystic fibrosis. J Pediatr. 1981 Feb; 98(2):218-22.
|
|
|
|
|
359.
|
Kleinmann RE, Kazarian EL, Raptopoulos V, Braverman LE. Primary empty sella and Rieger's anomaly of the anterior chamber of the eye: a familial syndrome. N Engl J Med. 1981 Jan 8; 304(2):90-3.
|
|
|
|
|
360.
|
Roti E, Fang SL, Emerson CH, Braverman LE. Placental inner ring iodothyronine deiodination: a mechanism for decreased passage of T4 and T3 from mother to fetus. Trans Assoc Am Physicians. 1981; 94:183-9.
|
|
|
|
|
361.
|
Theodoropoulos T, Fang SL, Azizi F, Ingbar SH, Vagenakis AG, Braverman LE. Effect of diphenylhydantoin on hypothalamic-pituitary-thyroid function in the rat. Am J Physiol. 1980 Dec; 239(6):E468-73.
|
|
|
|
|
362.
|
Sternthal E, Lipworth L, Stanley B, Abreau C, Fang SL, Braverman LE. Suppression of thyroid radioiodine uptake by various doses of stable iodide. N Engl J Med. 1980 Nov 6; 303(19):1083-8.
|
|
|
|
|
363.
|
Kapen S, Vagenakis A, Braverman L. Failure of a serotonergic receptor-blocking drug to change the twenty-four-hour luteinizing hormone secretory pattern in women. J Clin Endocrinol Metab. 1980 Aug; 51(2):302-6.
|
|
|
|
|
364.
|
Kleinmann RE, Vagenakis AG, Braverman LE. The effect of iopanoic acid on the regulation of thyrotropin secretion in euthyroid subjects. J Clin Endocrinol Metab. 1980 Aug; 51(2):399-403.
|
|
|
|
|
365.
|
Emerson CH, Braverman LE. Thyroid irradiation--one view. N Engl J Med. 1980 Jul 24; 303(4):217-9.
|
|
|
|
|
366.
|
El-Zaheri MM, Braverman LE, Vagenakis AG. Enhanced conversion of thyroxine to triiodothyronine by the neonatal rat pituitary. Endocrinology. 1980 Jun; 106(6):1735-9.
|
|
|
|
|
367.
|
Kleinmann RE, Braverman LE, Vagenakis AG, Butcher RW, Clark RB. A new method for measurement of human thyroid-stimulating immunoglobulins. J Lab Clin Med. 1980 Apr; 95(4):581-9.
|
|
|
|
|
368.
|
Braverman LE, Abreau CM, Brock P, Kleinmann R, Fournier L, Odstrchel G, Schoemaker HJ. Measurement of serum free thyroxine by RIA in various clinical states. J Nucl Med. 1980 Mar; 21(3):233-9.
|
|
|
|
|
369.
|
Coiro V, Harris A, Goodman HM, Vagenakis A, Braverman L. Effect of pharmacological quantities of infused 3,3',5'-triiodothyronine on thyroxine monodeiodination to 3,5,3'-triiodothyronine. Endocrinology. 1980 Jan; 106(1):68-75.
|
|
|
|
|
370.
|
Danforth E, Horton ES, O'Connell M, Sims EA, Burger AG, Ingbar SH, Braverman L, Vagenakis AG. Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest. 1979 Nov; 64(5):1336-47.
|
|
|
|
|
371.
|
Braverman LE, Vagenakis AG. The thyroid. Clin Endocrinol Metab. 1979 Nov; 8(3):621-39.
|
|
|
|
|
372.
|
Kleinmann RE, Vagenakis AG, Abreau C, Braverman LE. Anterior neck abscess masquerading as acute suppurative thyroiditis. J Nucl Med. 1979 Oct; 20(10):1051-2.
|
|
|
|
|
373.
|
Coiro V, Braverman LE, Christianson D, Fang SL, Goodman HM. Effect of hypothyroidism and thyroxine replacement on growth hormone in the rat. Endocrinology. 1979 Sep; 105(3):641-6.
|
|
|
|
|
374.
|
Theodoropoulos T, Braverman LE, Vagenakis AG. Iodide-induced hypothyroidism: a potential hazard during perinatal life. Science. 1979 Aug 3; 205(4405):502-3.
|
|
|
|
|
375.
|
Jackson R, Rosenberg C, Kleinmann R, Vagenakis AG, Braverman LE. Ophthalmopathy after neck irradiation therapy for Hodgkin's disease. Cancer Treat Rep. 1979 Aug; 63(8):1393-5.
|
|
|
|
|
376.
|
Theodoropoulos T, Braverman LE, Vagenakis AG. Thyrotropin-releasing hormone is not required for thyrotropin secretion in the perinatal rat. J Clin Invest. 1979 Apr; 63(4):588-94.
|
|
|
|
|
377.
|
Harris AR, Fang SL, Hinerfeld L, Braverman LE, Vagenakis AG. The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. J Clin Invest. 1979 Mar; 63(3):516-24.
|
|
|
|
|
378.
|
Winzelberg GG, Gore J, Yu D, Vagenakis AG, Braverman LE. Aspergillus flavus as a cause of thyroiditis in an immunosuppressed host. Johns Hopkins Med J. 1979 Mar; 144(3):90-3.
|
|
|
|
|
379.
|
Harris AR, Vagenakis AG, Braverman LE. Sex-related differences in outer ring monodeiodination of thyroxine and 3,3',5'-triiodothyronine by rat liver homogenates. Endocrinology. 1979 Mar; 104(3):645-52.
|
|
|
|
|
380.
|
Wall JR, Strakosch CR, Fang SL, Ingbar SH, Braverman LE. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide. Clin Endocrinol (Oxf). 1979 Jan; 10(1):79-91.
|
|
|
|
|
381.
|
Harris AR, Fang SL, Prosky J, Braverman LE, Vagenakis AG. Decreased outer ring monodeiodination of thyroxine and reverse triiodothyronine in the fetal and neonatal rat. Endocrinology. 1978 Dec; 103(6):2216-22.
|
|
|
|
|
382.
|
Harris AR, Fang SL, Vagenakis AG, Braverman LE. Effect of starvation, nutriment replacement, and hypothyroidism on in vitro hepatic T4 to T3 conversion in the rat. Metabolism. 1978 Nov; 27(11):1680-90.
|
|
|
|
|
383.
|
Roti E, Christianson D, Harris AR, Braverman LE, Vagenakis AG. "Short" loop feedback regulation of hypothalamic and brain thyrotropin-releasing hormone content in the rat and dwarf mouse. Endocrinology. 1978 Nov; 103(5):1662-7.
|
|
|
|
|
384.
|
Eisenstein Z, Hagg S, Vagenakis AG, Fang SL, Ransil B, Burger A, Balsam A, Braverman LE, Ingbar SH. Effect of starvation on the production and peripheral metabolism of 3,3',5'-triiodothyronine in euthyroid obese subjects. J Clin Endocrinol Metab. 1978 Oct; 47(4):889-93.
|
|
|
|
|
385.
|
Wall JR, Trewin A, Fang SL, Ingbar SH, Braverman LE. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest. 1978 Jul; 1(3):253-8.
|
|
|
|
|
386.
|
Sakurada T, Rudolph M, Fang SL, Vagenakis AG, Braverman LE, Ingbar SH. Evidence that triiodothyronine and reverse triiodothyronine are sequentially deiodinated in man. J Clin Endocrinol Metab. 1978 Jun; 46(6):916-22.
|
|
|
|
|
387.
|
Rudolph M, Sakurada T, Fang SL, Vagenakis AG, Braverman LE, Ingbar SH. Appearance of labeled metabolites in the serum of man after the administration of labeled thyroxine, triiodothyronine (T3), and reverse triiodothyronine (rT3). J Clin Endocrinol Metab. 1978 Jun; 46(6):923-8.
|
|
|
|
|
388.
|
Wall JR, Fang SL, Walters BA, Strakosch CR, Ingbar SH, Braverman LE. Multi-system immunologically mediated disease: T lymphocyte deficiency and thyroid immunologic disease--a report of four cases. Aust N Z J Med. 1978 Jun; 8(3):290-4.
|
|
|
|
|
389.
|
Braverman LE. Therapeutic considerations. Clin Endocrinol Metab. 1978 Mar; 7(1):221-40.
|
|
|
|
|
390.
|
Harris AR, Smith MS, Alex S, Salhanick HA, Vagenakis AG, Braverman LE. Pyridoxine (B6)-induced inhibition of prolactin release in the female rat. Endocrinology. 1978 Feb; 102(2):362-6.
|
|
|
|
|
391.
|
Harris AR, Christianson D, Smith MS, Fang SL, Braverman LE, Vagenakis AG. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat. J Clin Invest. 1978 Feb; 61(2):441-8.
|
|
|
|
|
392.
|
Vagenakis AG, Portnay GI, O'Brian JT, Rudolph M, Arky RA, Ingbar SH, Braverman LE. Effect of starvation on the production and metabolism of thyroxine and triiodothyronine in euthyroid obese patients. J Clin Endocrinol Metab. 1977 Dec; 45(6):1305-9.
|
|
|
|
|
393.
|
Abreau CM, Vagenakis AG, Roti E, Braverman LE. Clinical evaluation of a hemagglutination method for microsomal and thyroglobulin antibodies in autoimmune thyroid disease. Ann Clin Lab Sci. 1977 Jan-Feb; 7(1):73-8.
|
|
|
|
|
394.
|
Wall JR, Fang SL, Ingbar SH, Braverman LE. Lymphocyte transformation in response to human thyroid extract in patients with subacute thyroiditis. J Clin Endocrinol Metab. 1976 Sep; 43(3):587-90.
|
|
|
|
|
395.
|
Nicod P, Burger A, Strauch G, Vagenakis AG, Braverman LE. The failure of physiologic doses of reverse T3 to effect thyroid-pituitary function in man. J Clin Endocrinol Metab. 1976 Aug; 43(2):478-81.
|
|
|
|
|
396.
|
Vagenakis AG, Dole K, Braverman LE. Pituitary enlargement, pituitary failure, and primary hypothyroidism. Ann Intern Med. 1976 Aug; 85(2):195-8.
|
|
|
|
|
397.
|
Vagenakis AG, Braverman LE. Editorial: Thyroid function tests--which one? Ann Intern Med. 1976 May; 84(5):607-8.
|
|
|
|
|
398.
|
Burger A, Nicod P, Suter P, Vallotton MB, Vagenakis P, Braverman L. Reduced active thyroid hormone levels in acute illness. Lancet. 1976 Mar 27; 1(7961):653-5.
|
|
|
|
|
399.
|
Vagenakis AG, Braverman LE, Azizi F, Portinay GI, Ingbar SH. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N Engl J Med. 1975 Oct 2; 293(14):681-4.
|
|
|
|
|
400.
|
Vagenakis AG, Roti E, Mannix J, Braverman LE. Problems in the measurement of urinary TRH. J Clin Endocrinol Metab. 1975 Oct; 41(4):801-4.
|
|
|
|
|
401.
|
Vagenakis AG, Braverman LE. Adverse effects of iodides on thyroid function. Med Clin North Am. 1975 Sep; 59(5):1075-88.
|
|
|
|
|
402.
|
Serino T, MacDonnell K, Ishikawa S, Braverman L, Abreau CM, Johnston RP, Cloona E. Differential pulmonary residual volume determinations with radioactive xenon. J Lab Clin Med. 1975 Jul; 86(1):160-3.
|
|
|
|
|
403.
|
Vagenakis AG, Burger A, Portnary GI, Rudolph M, O'Brian JR, Azizi F, Arky RA, Nicod P, Ingbar SH, Braverman LE. Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab. 1975 Jul; 41(1):191-4.
|
|
|
|
|
404.
|
Azizi F, Vagenakis AG, Ingbar SH, Braverman LE. The time course of changes in TRH responsiveness in man following a single dose of liothyronine. Metabolism. 1975 Jun; 24(6):691-4.
|
|
|
|
|
405.
|
Azizi F, Vagenakis AG, Portnay GI, Rapoport B, Ingbar SH, Braverman LE. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations. N Engl J Med. 1975 Feb 6; 292(6):273-7.
|
|
|
|
|
406.
|
